Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

Pharma Giants Combine Forces to Fight New M&A Rules: https://g.foolcdn.com/editorial/images/749915/featured-daily-upside-image.png
Pharma Giants Combine Forces to Fight New M&A Rules

For more crisp and insightful business and economic news, subscribe to The Daily Upside newsletter It's completely free and we guarantee you'll learn something new every day.

Meet the

Why Shares of Conduit Pharmaceuticals Are Jumping Wednesday: https://g.foolcdn.com/editorial/images/749836/pharmaceutical-factory-worker.jpg
Why Shares of Conduit Pharmaceuticals Are Jumping Wednesday

Shares of Conduit Pharmaceuticals (NASDAQ: CDT) were up more than 17% on Wednesday as of 11:30 a.m., after jumping up as much as 81% in the first hour of trading, leading to a brief halt in trading

2 High-Yield Dividend Stocks to Buy in October: https://g.foolcdn.com/editorial/images/749670/time-to-buy.jpg
2 High-Yield Dividend Stocks to Buy in October

High-yield dividend stocks are a powerful way to boost a portfolio's annual performance. By reinvesting the dividend and regularly buying more shares, these stocks can produce impressive returns

Is AT&T Stock a Buy Now?: https://g.foolcdn.com/editorial/images/749599/using-smartphone-while-outside.jpg
Is AT&T Stock a Buy Now?

AT&T (NYSE: T) has frustrated investors for years. Costly missteps, a massive debt burden, and a dividend cut after years of annual increases progressively soured investors, so much so that it

3 High-Yielding Dividend Growth Stocks That Have Increased Their Payouts by 50% in 5 Years: https://g.foolcdn.com/editorial/images/749431/a-person-counting-money-in-their-living-room.jpg
3 High-Yielding Dividend Growth Stocks That Have Increased Their Payouts by 50% in 5 Years

If you're investing in a dividend stock, there's more than just the yield and the payout ratio to consider. It's also important to look at dividend increases -- whether the company has been making

Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc: https://mms.businesswire.com/media/20210505005534/en/876086/5/5009664_Horizon_Logo_Full-Color_CMYK_M01_%281%29.jpg
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
EQS-News: Newron to present three posters on its clinical program evaluating evenamide in the treatment of schizophrenia at the 36th European College of Neuropsychopharmacology Congress: https://mms.businesswire.com/media/20200216005057/en/682845/5/logo_color_high_res.jpg
EQS-News: Newron to present three posters on its clinical program evaluating evenamide in the treatment of schizophrenia at the 36th European College of Neuropsychopharmacology Congress
EQS-News: Newron to present three posters on its clinical program evaluating evenamide in the treatment of schizophrenia at the 36th European College of Neuropsychopharmacology Congress
Intellia Therapeutics Could Rise 167%, Per Wall Street, But Is It a Buy?: https://g.foolcdn.com/editorial/images/749323/three-scientists-work-in-laboratory-with-one-looking-down-a-microscope.jpg
Intellia Therapeutics Could Rise 167%, Per Wall Street, But Is It a Buy?

Wall Street analysts are quite bullish right now on gene-editing specialist Intellia Therapeutics (NASDAQ: NTLA) -- expecting, on average, the stock to soar 167% in the coming 12 months. Yet

Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc: https://mms.businesswire.com/media/20210505005534/en/876086/5/5009664_Horizon_Logo_Full-Color_CMYK_M01_%281%29.jpg
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
Is Pfizer Stock a Buy Now?: https://g.foolcdn.com/editorial/images/749520/gettyimages-an-investor-reads-something-on-his-phone.jpg
Is Pfizer Stock a Buy Now?

Pfizer (NYSE: PFE) sells a wide variety of medicines across treatment areas such as autoimmune diseases and oncology. But it probably is most known for its leading coronavirus vaccine, which helped

2 Top Biotech Stocks to Buy in October: https://g.foolcdn.com/editorial/images/749514/gettyimages-1357572936.jpg
2 Top Biotech Stocks to Buy in October

Biotech stocks offer us a wide range of investing opportunities. You could buy shares of a research stage company and bet on a potential game-changing product that may launch several years from now

Why Rocket Lab Stock Fell Out of Orbit in September: https://g.foolcdn.com/editorial/images/749588/rocket-launch-getty.jpg
Why Rocket Lab Stock Fell Out of Orbit in September

The pristine two-year track record of successful launches by Rocket Lab USA (NASDAQ: RKLB) went up in smoke in September, and the rocket wasn't the only thing that crashed. Shares of Rocket Lab fell

Why Invitae Stock Popped Today: https://g.foolcdn.com/editorial/images/749585/doctor-examines-cancer-patient.jpg
Why Invitae Stock Popped Today

Shares of Invitae (NYSE: NVTA) roared as much as 37% higher early Monday, then settled to trade up 13% as of 3 p.m. ET after the U.S Food and Drug Administration (FDA) authorized marketing efforts

Got $1,000? 2 No-Brainer Stocks to Buy: https://g.foolcdn.com/editorial/images/749185/pharmacist-talking-to-patient.jpg
Got $1,000? 2 No-Brainer Stocks to Buy

Sometimes it's hard to know which stocks to pick amid the dozens of options available on equity markets. But occasionally, some companies look so attractive that the decision isn't so difficult

3 Top Stocks to Buy in October and Hold Forever: https://g.foolcdn.com/editorial/images/749259/fall-hands-with-laptop.jpg
3 Top Stocks to Buy in October and Hold Forever

Healthcare in the United States is big business: Experts believe the system could generate more than $6 trillion in annual spending by 2030. That's an opportunity for investors to find the key

VALBIOTIS SA: the Phase II/III REVERSE-IT study selected for an oral presentation at the 2023 EASD congress, the main European learned society for diabetes: https://mms.businesswire.com/media/20200205005659/en/689755/5/valbiotis-logo.jpg
VALBIOTIS SA: the Phase II/III REVERSE-IT study selected for an oral presentation at the 2023 EASD congress, the main European learned society for diabetes
VALBIOTIS SA: the Phase II/III REVERSE-IT study selected for an oral presentation at the 2023 EASD congress, the main European learned society for diabetes
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc: https://mms.businesswire.com/media/20210505005534/en/876086/5/5009664_Horizon_Logo_Full-Color_CMYK_M01_%281%29.jpg
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
EQS-News:  Newron appoints Margarita Chavez as board advisor: https://mms.businesswire.com/media/20200216005057/en/682845/5/logo_color_high_res.jpg
EQS-News:  Newron appoints Margarita Chavez as board advisor
EQS-News:  Newron appoints Margarita Chavez as board advisor
3 Revolutionary Stocks I'd Buy Right Now Without Hesitation: https://g.foolcdn.com/editorial/images/749045/doctor-smiling-and-holding-patients-hand.jpg
3 Revolutionary Stocks I'd Buy Right Now Without Hesitation

The healthcare industry evolves rapidly. Those companies that stay relevant often do so by breaking new ground. So it's a good idea for investors looking for exciting healthcare stocks to look at

3 Stocks to Buy in October That Could Soar More Than 40% Over the Next 12 Months, According to Wall Street: https://g.foolcdn.com/editorial/images/748648/young-couple-writing-laptop.jpg
3 Stocks to Buy in October That Could Soar More Than 40% Over the Next 12 Months, According to Wall Street

Is the stock market surge of 2023 running out of steam? That seems to be the case. The S&P 500 has retreated from the lofty levels of just a couple of months ago.

But there are some stocks that

Could Viatris Stock Help You Become a Millionaire?: https://g.foolcdn.com/editorial/images/748876/rich-person-standing-next-to-a-jet-and-convertible.jpg
Could Viatris Stock Help You Become a Millionaire?

If you're investing $25,000 in your stock portfolio, then getting that investment to be worth $1 million over time is no simple task. Odds are, you'll have to wait decades for that investment to

3 Magnificent Dividend Stocks to Buy in October: https://g.foolcdn.com/editorial/images/749203/dividend-income.jpg
3 Magnificent Dividend Stocks to Buy in October

There's no better time than October to invest in high-quality dividend stocks. That's because the new month offers a chance to get those dividend payments flowing sooner rather than later.

Three

Stock Split Watch: Is Regeneron Pharmaceuticals Next?: https://g.foolcdn.com/editorial/images/749166/gettyimages-1199696916.jpg
Stock Split Watch: Is Regeneron Pharmaceuticals Next?

Companies generally decide to engage in stock splits after their shares have soared to a level that may put them out of reach for many retail investors. A stock split doesn't change the real market

Why Pfizer and BioNTech Stocks Zoomed Higher Today: https://g.foolcdn.com/editorial/images/749422/person-smiling-while-showing-off-fresh-vaccine-shot.jpg
Why Pfizer and BioNTech Stocks Zoomed Higher Today

Americans might not be as coronavirus-weary as some fear. Actually, these days they might be more coronavirus-wary. On the back of early take-up data for the latest COVID-19 vaccines that came out

1 Super Semiconductor Stock Down 21% You'll Wish You'd Bought on the Dip: https://g.foolcdn.com/editorial/images/748881/a-digital-image-of-a-semiconductor-network-with-a-car-imprinted-in-the-center.jpg
1 Super Semiconductor Stock Down 21% You'll Wish You'd Bought on the Dip

Over the past few years, investors have paid a growing amount of attention to semiconductor stocks. Advanced chips are powering an increasing number of products and services, including electric